Prof. Dr. Laura van 't Veer was honored with the Luigi Castagnetta Award at a breast cancer symposium in Sicily.
On November 14, 2024, Agendia announced that Prof. Dr. Laura van 't Veer would receive the Luigi Castagnetta Award at a prestigious breast cancer symposium held in Sicily, Italy.
This award, named after the noted Italian oncologist and researcher Luigi Castagnetta, honors individuals who have made significant, lasting contributions to breast cancer research and molecular diagnostics. Van 't Veer's recognition reflected her decades-long career developing genomic tools, most notably MammaPrint, that have reshaped how clinicians assess and manage breast cancer risk.
The award ceremony took place as part of a broader wave of international recognition for van 't Veer in late 2024, which also included honors in the Netherlands and the United States, underscoring the global and enduring impact of her scientific contributions nearly a quarter-century after her initial discoveries.
Being honored in Italy, a country with a strong tradition of breast cancer research, further validated the international reach of her work beyond the Netherlands and the United States, where she had spent much of her career. The recognition highlighted her ongoing influence as a mentor and thought leader in molecular oncology even as she continued her research and advisory roles well into her sixties.